…for Feverflux, our latest development for the American market offering precise core body temperature measurement. Feverflux will shortly be launched once FDA 510 (k) approval has been obtained. More to follow soon...
With CORE and calera®, greenteg wins three CES Innovation Awards in the Health & Wellness, Sports & Fitness, and Wearable Technologies categories. calera® is introduced as a new brand name for medtech and wearable applications. With the relaunch of the company website, another important milestone is reached – and greenteg is perfectly equipped for the next funding round.
greenteg presents the CORE sensor to a broader market by exhibiting at the major EUROBIKE and MEDICA trade fairs. In the summer, various professional athletes use CORE in the Tour de France and other races, along with ten gold-medal winners at the Olympic Games in Tokyo. Launch of several products by partners using greenteg’s calera® technology.
During the first wave of COVID-19, greenteg supports clinical research with CORE prototypes for measuring core body temperature. A little later, the FDA grants emergency use authorization. The German cycling team BORA-hansgrohe uses CORE sensors during the Tour de France. And greenteg gSKIN® sensors reach the International Space Station (ISS) on an unmanned supply vehicle launched by JAXA.
greenteg presents its CORE prototypes at the world’s largest tech show, CES in Las Vegas. The same year, it moves to new premises at Zurich Airport – covering >1,000 m². greenteg is awarded the Horizon Europe 2020 Seal of Excellence and a grant from Innosuisse for a sensor that can detect neurodegenerative disease at an early stage. The company also exhibits at the MEDICA medical technology fair.
Investment round to further grow the business and production capacity. Business development of core body temperature measurement technology is especially targeted with investment funding, and initial prototypes are tested in a clinical environment and with partners.
With a focus on the growing wearables industry, greenteg also raises its profile by participating in the Web Summit and Swiss Medtech Day. An exclusive photonics partnership with Thorlabs Inc. begins.
Successful conclusion of another funding round with a promising prototype. The first wearable for the R&D sector offering core body temperature monitoring is launched, leading to increased interest from current and new investors.
With the gSKIN® Kit, greenteg tackles U-value measurement in the building sector. With the launch of this product, the prospering company is now already operating successfully in three business fields.
The first gRAY® sensors are sold to Thorlabs Inc., a global company and market leader in devices and components for generating and measuring laser sources as well as optical coherence tomography and photoacoustic analysis equipment.
greenteg expands and moves into Technopark Zurich, where its office and production facilities are expanded to >200 m². The company successfully completes the rocky seed period, obtains patents for three developments as well as several trademarks, and achieves market readiness with heat flux sensors for the R&D sector.
Seed funding is obtained for greenteg’s sensor technology, which wins various awards and innovation prizes, including ClimateKIC, InnoSuisse and the W.A. de Vigier Award. greenteg is also named one of the top 100 Swiss start-ups.
greenteg’s success story begins in Zurich in 2009. The company is founded as a spin-off of ETH Zurich, the Swiss Federal Institute of Technology. Its technology is based on a scalable heat flux sensor developed at ETH Zurich’s Chair of Micro- and Nanosystems.